跳转至内容
Merck
  • In vitro selective inhibition of human UDP-glucuronosyltransferase (UGT) 1A4 by finasteride, and prediction of in vivo drug-drug interactions.

In vitro selective inhibition of human UDP-glucuronosyltransferase (UGT) 1A4 by finasteride, and prediction of in vivo drug-drug interactions.

Toxicology letters (2014-12-03)
Seung Jun Lee, Jung Bae Park, Doyun Kim, Soo Hyeon Bae, Young-Won Chin, Euichaul Oh, Soo Kyung Bae
摘要

In the present study, we evaluated the inhibitory potentials of finasteride for the major human hepatic UDP-glucuronosyltransferases (UGTs) (UGT1A1, UGT1A3, UGT1A4, UGT1A6, UGT1A9, UGT2B7, and UGT2B15) in vitro using LC-MS/MS by specific marker reactions in human liver microsomes (except for UGT2B15) or recombinant supersomes (UGT2B15). Of the seven tested UGTs, finasteride potently, selectively, and competitively inhibited UGT1A4-mediated trifluoperazine-N-glucuronidation in human liver microsomes with an IC₅₀ value of 11.5 ± 1.78 μM and Ki value of 6.03 ± 0.291 μM. This inhibitory potency was similar to that of hecogenin, a well-known inhibitor of UGT1A4. However, finasteride did not seem to inhibit any of the other six UGTs: UGT1A1, UGT1A3, UGT1A6, UGT1A9, UGT2B7, or UGT2B15. Similarly, finasteride markedly inhibited UGT1A4 activity in recombinant human UGT1A4 supersomes, with a Ki value of 6.05 ± 0.410 μM. In addition, finasteride strongly inhibited UGT1A4-catalyzed imipramine-N-β-D-glucuronidation. However, on the basis of an in vitro-in vivo extrapolation, our data strongly suggested that finasteride is unlikely to cause clinically significant drug-drug interactions mediated via inhibition of the hepatic UGT enzymes involved in drug metabolism in vivo.

材料
货号
品牌
产品描述

Sigma-Aldrich
3-(2-氨乙酸)吲哚 盐酸盐, powder
Sigma-Aldrich
尿核甙, ≥99%
Sigma-Aldrich
尿核甙, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
茶碱, anhydrous, ≥99%, powder
Sigma-Aldrich
4-甲基伞形酮, ≥98%
Sigma-Aldrich
1-萘酚, ReagentPlus®, ≥99%
Sigma-Aldrich
鹅去氧胆酸
Sigma-Aldrich
非那雄胺, ≥98% (HPLC), powder
Sigma-Aldrich
丙泊酚, 97%
Sigma-Aldrich
1-萘酚, puriss. p.a., reag. Ph. Eur., ≥99% (GC)
Sigma-Aldrich
氟尼酸
Sigma-Aldrich
3′-叠氮-3′-脱氧胸苷, ≥98% (HPLC)
Sigma-Aldrich
尿核甙, BioUltra, ≥99%
Sigma-Aldrich
三氟拉嗪 二盐酸盐, ≥99%, powder
Sigma-Aldrich
依法韦伦, ≥98% (HPLC)
Supelco
茶碱, Pharmaceutical Secondary Standard; Certified Reference Material
USP
茶碱, United States Pharmacopeia (USP) Reference Standard
Supelco
齐多夫定, Pharmaceutical Secondary Standard; Certified Reference Material
USP
齐多夫定, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
β-D-阿洛糖, rare aldohexose sugar
普鲁泊福, European Pharmacopoeia (EP) Reference Standard
茶碱, European Pharmacopoeia (EP) Reference Standard
USP
三氟拉嗪 盐酸盐, United States Pharmacopeia (USP) Reference Standard
鹅去氧胆酸, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
三氟拉嗪 盐酸盐, meets USP testing specifications
Sigma-Aldrich
1-萘酚, BioXtra, ≥99%
非那雄胺, European Pharmacopoeia (EP) Reference Standard
Supelco
氯磺丙脲, analytical standard, ≥97%
羟甲香豆素, European Pharmacopoeia (EP) Reference Standard
氟尼酸, European Pharmacopoeia (EP) Reference Standard